Good recap on the state of affairs.
First time I've read the the full study in Neurology (https://n.neurology.org/content/neurology/92/16/e1912.full.pdf).
Slightly concerned about the 56 % of diarrhea in the high dose. Hopefully it doesn't impact the ability for long term use of the drug.
- Forums
- ASX - By Stock
- NEU
- Ann: Neuren Corporate Presentation, October 2019
Ann: Neuren Corporate Presentation, October 2019, page-14
-
- There are more pages in this discussion • 67 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$13.71 |
Change
-0.040(0.29%) |
Mkt cap ! $1.762B |
Open | High | Low | Value | Volume |
$13.85 | $14.08 | $13.46 | $3.738M | 273.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 2184 | $13.70 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.72 | 87 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 2064 | 13.690 |
7 | 779 | 13.680 |
7 | 726 | 13.670 |
6 | 581 | 13.660 |
7 | 666 | 13.650 |
Price($) | Vol. | No. |
---|---|---|
13.700 | 584 | 10 |
13.710 | 476 | 6 |
13.720 | 523 | 6 |
13.730 | 1233 | 5 |
13.740 | 445 | 3 |
Last trade - 13.20pm 10/09/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |